BR0307236A - Processo para fabricação de compostos orgânicos - Google Patents

Processo para fabricação de compostos orgânicos

Info

Publication number
BR0307236A
BR0307236A BR0307236-3A BR0307236A BR0307236A BR 0307236 A BR0307236 A BR 0307236A BR 0307236 A BR0307236 A BR 0307236A BR 0307236 A BR0307236 A BR 0307236A
Authority
BR
Brazil
Prior art keywords
organic compounds
manufacturing organic
dihydroxyester
ketoester
hydroxy
Prior art date
Application number
BR0307236-3A
Other languages
English (en)
Inventor
Guang-Pei Chen
Prasad Koteswara Kapa
Eric M Loeser
Ulrich Beutler
Werner Zaugg
Michael J Girgis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0307236A publication Critical patent/BR0307236A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms

Abstract

"PROCESSO PARA FABRICAçãO DE COMPOSTOS ORGâNICOS". A presente invenção refere-se a um processo para preparação de um sal de metal alcalino compreendendo: (a) condensação de um dissiloxidieno com um aldeído na presença de um catalisador de titânio (IV) em um solvente inerte para formar um 5(S)-hidróxi-3-cetoéster; (b) redução do 5(S)-hidróxi-3-cetoéster para um 3(R),5(S)-dihidroxiéster na presença de um di(alquil inferior) metoxiborano; e (c) hidrólise de 3(R),5(S)-dihidroxiéster na presença de uma base aquosa para formar um sal de metal alcalino.
BR0307236-3A 2002-01-28 2003-01-27 Processo para fabricação de compostos orgânicos BR0307236A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35231602P 2002-01-28 2002-01-28
US38318802P 2002-05-24 2002-05-24
PCT/EP2003/000804 WO2003064382A2 (en) 2002-01-28 2003-01-27 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
BR0307236A true BR0307236A (pt) 2004-12-07

Family

ID=27669055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307236-3A BR0307236A (pt) 2002-01-28 2003-01-27 Processo para fabricação de compostos orgânicos

Country Status (19)

Country Link
US (3) US6835838B2 (pt)
EP (1) EP1472227B1 (pt)
JP (1) JP2005516064A (pt)
KR (2) KR20100091267A (pt)
CN (2) CN1625550A (pt)
AU (4) AU2003239294B2 (pt)
BR (1) BR0307236A (pt)
CA (1) CA2472340A1 (pt)
CO (1) CO5601045A2 (pt)
EC (1) ECSP045202A (pt)
IL (1) IL162817A0 (pt)
MX (1) MXPA04007308A (pt)
NO (1) NO327363B1 (pt)
NZ (3) NZ554367A (pt)
PL (1) PL371383A1 (pt)
RU (1) RU2360903C2 (pt)
SG (2) SG157225A1 (pt)
WO (1) WO2003064382A2 (pt)
ZA (1) ZA200405239B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301977C (zh) 2001-07-13 2007-02-28 阿斯特拉曾尼卡英国有限公司 氨基嘧啶化合物的制备方法
KR100919941B1 (ko) * 2001-11-14 2009-10-05 닛산 가가쿠 고교 가부시키 가이샤 광학활성 옥소헵텐산 에스테르의 제조방법
WO2003064392A1 (en) * 2002-01-31 2003-08-07 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
WO2004026838A1 (en) * 2002-09-20 2004-04-01 Nissan Chemical Industries, Ltd. Method for producing a 3,5-dihydroxy-6-heptenoate
US20060142582A1 (en) * 2003-02-12 2006-06-29 Van Der Schaaf Paul A Crystalline forms of pitavastatin calcium
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
TWI328006B (en) 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN1763015B (zh) * 2004-10-22 2011-06-22 四川抗菌素工业研究所有限公司 一种罗舒伐他汀及其药用盐的制备方法及中间体
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
ES2564250T3 (es) * 2006-05-03 2016-03-21 Msn Laboratories Private Limited Nuevo proceso para estatinas y sus sales farmacéuticamente aceptables de las mismas
SI2086945T1 (sl) * 2006-10-09 2016-05-31 Msn Laboratories Private Limited Novi postopek za pripravo statinov in njihovih farmacevtsko sprejemljivih soli
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
US8487105B2 (en) * 2009-01-19 2013-07-16 Msn Laboratories Limited Process for preparing pitavastatin, intermediates and pharmaceuctically acceptable salts thereof
WO2011086584A2 (en) 2010-01-18 2011-07-21 Msn Laboratories Limited Improved process for the preparation of amide intermediates and their use thereof
EP2423195A1 (en) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
JP2013536219A (ja) 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
EP3178812A1 (en) * 2010-11-12 2017-06-14 Hetero Research Foundation Novel polymorphs of pitavastatin calcium
WO2012140490A2 (en) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Process for preparing quinoline derivative
CN103755568B (zh) * 2013-12-10 2015-10-28 江西科技师范大学 IeodomycinA和B立体选择性合成方法
JP6704916B2 (ja) 2015-08-05 2020-06-03 株式会社エーピーアイ コーポレーション ピタバスタチンカルシウムの製造方法
CN108976168B (zh) * 2017-06-02 2020-09-25 浙江京新药业股份有限公司 一种匹伐他汀半钙盐晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3528186B2 (ja) * 1991-06-24 2004-05-17 日産化学工業株式会社 光学活性キノリンメバロン酸のジアステレオマー塩
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3554036B2 (ja) * 1994-09-06 2004-08-11 宇部興産株式会社 光学活性な７−置換キノリル−３，５−ジヒドロキシ−ヘプト−６−エン酸エステル誘導体の製造方法
KR100919941B1 (ko) * 2001-11-14 2009-10-05 닛산 가가쿠 고교 가부시키 가이샤 광학활성 옥소헵텐산 에스테르의 제조방법
EP2125754B1 (en) * 2007-02-08 2012-04-11 Aurobindo Pharma Limited Process for preparation of rosuvastatin calcium

Also Published As

Publication number Publication date
WO2003064382A2 (en) 2003-08-07
EP1472227B1 (en) 2016-04-27
KR20040077883A (ko) 2004-09-07
AU2006225206B2 (en) 2009-08-06
RU2004126448A (ru) 2005-06-27
EP1472227A2 (en) 2004-11-03
US20040249154A1 (en) 2004-12-09
NO327363B1 (no) 2009-06-15
JP2005516064A (ja) 2005-06-02
US7572917B2 (en) 2009-08-11
US20090299065A1 (en) 2009-12-03
AU2009208129A1 (en) 2009-09-03
CN1660818A (zh) 2005-08-31
US6835838B2 (en) 2004-12-28
AU2006225205B2 (en) 2009-08-06
ECSP045202A (es) 2004-09-28
WO2003064382A3 (en) 2003-12-11
IL162817A0 (en) 2005-11-20
CO5601045A2 (es) 2006-01-31
AU2003239294B2 (en) 2006-10-19
NO20043586L (no) 2004-10-07
PL371383A1 (en) 2005-06-13
NZ554366A (en) 2008-11-28
CN100378081C (zh) 2008-04-02
CA2472340A1 (en) 2003-08-07
KR20100091267A (ko) 2010-08-18
CN1625550A (zh) 2005-06-08
AU2006225206A1 (en) 2006-10-26
US20030208072A1 (en) 2003-11-06
NZ554367A (en) 2008-11-28
NZ534136A (en) 2007-08-31
SG161742A1 (en) 2010-06-29
MXPA04007308A (es) 2004-10-29
AU2006225205A1 (en) 2006-10-26
ZA200405239B (en) 2005-07-27
SG157225A1 (en) 2009-12-29
RU2360903C2 (ru) 2009-07-10

Similar Documents

Publication Publication Date Title
BR0307236A (pt) Processo para fabricação de compostos orgânicos
BRPI0407967A (pt) processo de uma etapa para a preparação de derivados anticonvulsivantes
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
BR0112693A (pt) (derivados) de ácido sulfonilaminometilbenzóico substituìdos e processo para preparação do mesmo
BR0112538A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
BR0012212A (pt) Processo de hidrogenação de 3-hidroxipropanal em 1,3-propanodiol, processo de preparação de 1,3-propanodiol, processo de purificação de uma solução aquosa de 3-hidroxipropanal e composição de 1,3-propanodiol
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
TW200716582A (en) Process for making a pharmaceutical compound
BRPI0507979A (pt) processo para preparação de um composto
BR0215097A (pt) Processo para fazer o composto da fórmula e composto da fórmula
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR0208861A (pt) Processo para a preparação de um composto, e, composto
BR9808854A (pt) Processo para preparação de um composto, e, composto
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas
BR0108990A (pt) Processo para preparação de derivados de pirimidona com atividade antifungos
BR0212390A (pt) Processo para a preparação de cilastatina
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
DE602004020632D1 (de) Verfahren zur herstellung einer alpha-1-antitrypsinlösung
BR0311699A (pt) Processo para a decomposição de hidroperóxido de cicloexila
BRPI0409235A (pt) processo para a produção de sal de amÈnio do ácido 2-hidróxi-4-metiltiobutìrico
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
BRPI0407448A (pt) Processo quìmico
BR0314306A (pt) Processo para produção de um álcool pela hidrogenação de um aldeìdo alifático sobre um catalisador
BR0214971A (pt) Processo para a produção de um imunossupressor

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]